What does AS Ophtalmologie do?

AS Ophtalmologie is a specialist medical practice in Walhain. Private Limited, started on 7 October 2016, 1 establishment.

What is the address of AS Ophtalmologie?

The registered office of AS Ophtalmologie is located at Rue du Tilleul(WSP) 21, 1457 Walhain.

Is AS Ophtalmologie still active?

Yes. According to the CBE (18 September 2026) AS Ophtalmologie is active, legal situation “Normale toestand”, started on 7 October 2016.

Is AS Ophtalmologie registered on Peppol?

Yes, AS Ophtalmologie is registered on the Peppol network with ID 0208:0663942531.

What is the enterprise number of AS Ophtalmologie?

The enterprise number of AS Ophtalmologie is BE0663942531.

When was AS Ophtalmologie founded?

AS Ophtalmologie was founded on 7 October 2016.

Who are the directors of AS Ophtalmologie?

According to the 2025 annual accounts, the directors of AS Ophtalmologie are: Antoine Stinglhamber.

Is AS Ophtalmologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 October 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did AS Ophtalmologie make in 2025?

AS Ophtalmologie posted a profit after taxes of € 243,515 in financial year 2025.

What is the revenue of AS Ophtalmologie?

As a small company, AS Ophtalmologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 356,400.

AS Ophtalmologie (Private Limited) - Walhain

Dossier AS Ophtalmologie, printed on 18 September 2026 from databakkes.be/en/0663942531/as-ophtalmologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

AS Ophtalmologie from Walhain, company number BE0663942531, closed financial year 2025 with a result of € 243,515 after tax. For that financial year AS Ophtalmologie recorded a gross margin of € 356,400 and equity of € 20,460. Compared with financial year 2024, the result moved from € 270,032 to € 243,515. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What it is worth Healthy

€ 20,460

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 243,515

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 87,728

▲ 97% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 243,515 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 32,649

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 54,573

▼ 24% vs 2024

€ 17,500 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,313

▲ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 0

▼ € 14,894 vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 352,058 Gross margin 2022: € 352,058 First fiscal year in the series	€ 373,822 Gross margin 2023: € 373,822 ▲ 6% vs 2022 (€ 352,058) Favourable step	€ 409,798 Gross margin 2024: € 409,798 ▲ 10% vs 2023 (€ 373,822) Favourable step	€ 356,400 Gross margin 2025: € 356,400 ▼ 13% vs 2024 (€ 409,798) Unfavourable step	▼ 13%
Profit after taxes	€ 259,394 Profit after taxes 2022: € 259,394 First fiscal year in the series	€ 204,327 Profit after taxes 2023: € 204,327 ▼ 21% vs 2022 (€ 259,394) Unfavourable step	€ 270,032 Profit after taxes 2024: € 270,032 ▲ 32% vs 2023 (€ 204,327) Favourable step	€ 243,515 Profit after taxes 2025: € 243,515 ▼ 10% vs 2024 (€ 270,032) Unfavourable step	▼ 10%
Equity	€ 20,460 Equity 2022: € 20,460 First fiscal year in the series	€ 20,460 Equity 2023: € 20,460 Unchanged (€ 20,460) Unchanged	€ 20,460 Equity 2024: € 20,460 Unchanged (€ 20,460) Unchanged	€ 20,460 Equity 2025: € 20,460 Unchanged (€ 20,460) Unchanged
Total debts	€ 428,606 Total debts 2022: € 428,606 First fiscal year in the series	€ 306,843 Total debts 2023: € 306,843 ▼ 28% vs 2022 (€ 428,606) Favourable step	€ 308,501 Total debts 2024: € 308,501 ▲ 1% vs 2023 (€ 306,843) Unfavourable step	€ 267,133 Total debts 2025: € 267,133 ▼ 13% vs 2024 (€ 308,501) Favourable step	▼ 13%
Cash	€ 180,033 Cash 2022: € 180,033 First fiscal year in the series	€ 107,799 Cash 2023: € 107,799 ▼ 40% vs 2022 (€ 180,033) Unfavourable step	€ 44,424 Cash 2024: € 44,424 ▼ 59% vs 2023 (€ 107,799) Unfavourable step	€ 87,728 Cash 2025: € 87,728 ▲ 97% vs 2024 (€ 44,424) Favourable step	▲ 97%
Retained profit	€ 1,860 Retained profit 2022: € 1,860 First fiscal year in the series	€ 1,860 Retained profit 2023: € 1,860 Unchanged (€ 1,860) Unchanged	€ 1,860 Retained profit 2024: € 1,860 Unchanged (€ 1,860) Unchanged	€ 1,860 Retained profit 2025: € 1,860 Unchanged (€ 1,860) Unchanged
Dividend	€ 361,167 Dividend 2022: € 361,167 First fiscal year in the series	€ 204,327 Dividend 2023: € 204,327 ▼ 43% vs 2022 (€ 361,167) Unchanged	€ 270,032 Dividend 2024: € 270,032 ▲ 32% vs 2023 (€ 204,327) Unchanged	€ 243,515 Dividend 2025: € 243,515 ▼ 10% vs 2024 (€ 270,032) Unchanged	▼ 10%
Bank debt	€ 81,997 Bank debt 2022: € 81,997 First fiscal year in the series	€ 69,149 Bank debt 2023: € 69,149 ▼ 16% vs 2022 (€ 81,997) Favourable step	€ 71,517 Bank debt 2024: € 71,517 ▲ 3% vs 2023 (€ 69,149) Unfavourable step	€ 54,573 Bank debt 2025: € 54,573 ▼ 24% vs 2024 (€ 71,517) Favourable step	▼ 24%
Balance sheet total	€ 449,066 Balance sheet total 2022: € 449,066 First fiscal year in the series	€ 348,978 Balance sheet total 2023: € 348,978 ▼ 22% vs 2022 (€ 449,066) Unchanged	€ 371,939 Balance sheet total 2024: € 371,939 ▲ 7% vs 2023 (€ 348,978) Unchanged	€ 309,422 Balance sheet total 2025: € 309,422 ▼ 17% vs 2024 (€ 371,939) Unchanged	▼ 17%

Key figures of AS Ophtalmologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to AS Ophtalmologie?

What happened at AS Ophtalmologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 26, 2026 New annual accounts for financial year 2025: profit of € 243,515 (▼ 10% vs 2024). Source: NBB ↗
Oct 7, 2016 New establishment in Walhain. KBO
Oct 7, 2016 Start of the company according to the CBE. KBO

In short

From € 259,394 profit in 2022 to € 243,515 profit in 2025.

Paid € 310,216 in corporate taxes since 2022.

Best year ever: 2024, with € 270,032 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at AS Ophtalmologie? We notify you, reason included.

Follow AS Ophtalmologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Antoine Stinglhamber

AS Ophtalmologie

La Croisette

Behind AS Ophtalmologie is Antoine Stinglhamber. Antoine Stinglhamber is also behind La Croisette.

See the full network in the app

Directors

According to the 2025 annual accounts

Antoine Stinglhamber

Director

Also active at: La Croisette

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Tilleul(WSP) 21

1457 Walhain

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SL Radiologie

€ 457,879 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0663.942.531
VAT number: BE 0663.942.531
Registered office: Rue du Tilleul(WSP) 21, 1457 Walhain
Names & denominations: AS Ophtalmologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 October 2016
Peppol: Active · Active since 29 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗